This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "20160406 PLA call"

From HL7Wiki
Jump to navigation Jump to search
Line 131: Line 131:
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
*[[20160420 PLA call]]
 
*[[20160420 PLA call]]
 +
*• Follow-up with InM re: V2 methodology responsibilities (meeting 4/11)
  
 
|}
 
|}
  
 
© 2016 Health Level Seven® International.  All rights reserved
 
© 2016 Health Level Seven® International.  All rights reserved

Revision as of 17:14, 6 April 2016

return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program

HL7 PLA Call Minutes

Location: Phone: +1 770-657-9270, Participant Code: 985371,
https://global.gotomeeting.com/join/177894709

Date: 2016-04-06
Time: 2PM
Facilitator Mary Kay/ Austin Note taker(s) Anne
Attendee Name


Calvin Beebe
Woody Beeler
Lorraine Constable
Bo Dagnall
Jean Duteau,
Rick Haddorff
Tony Julian
Paul Knapp
Austin Kreisler,
Lynn Laakso
Mary Kay McDaniel
Brian Pech
John Quinn
John Roberts
Andy Stechishin
no quorum definition

Agenda

Agenda review

  • Notes of 20160323_PLA_call review
  • Discussion Topics
    • Continue discussion of CDA product family
    • Discuss updates needed for TSC and Co-Chair dinner in Montreal (May WGM) and TSC General Session Remarks write-up
  • notional division of products into product families and lines, to provide examples for peer review.
    • Level of granularity
    • Identify which pieces are orphaned, and the political elements to be surfaced.
    • Positioning cross-product family artifacts (standards naming)
  • BAM-lite feedback and review
    • Governance on V2.x (v2.9 substantive changes)
    • develop form to request establishing a Product Family

Minutes

Convened

Adjourned

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items
  • 20160420 PLA call
  • • Follow-up with InM re: V2 methodology responsibilities (meeting 4/11)

© 2016 Health Level Seven® International. All rights reserved